Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1993-08-06
1997-04-08
Knode, Marian C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 18, 514807, 530315, 530330, A61K 3807, A61K 3808
Patent
active
056187912
ABSTRACT:
The invention is a class of memory enhancing peptides having the general formula:
REFERENCES:
patent: 4410511 (1983-10-01), de Wied et al.
patent: 4487765 (1984-12-01), de Wied
patent: 4593017 (1986-06-01), de Wied
patent: 4623640 (1986-11-01), de Wied
patent: 5112947 (1992-05-01), Masaki et al.
Gregoriadis et al (1993) Trends in Biotech.11:440-442.
Harlow et al (1988) "Antibodies:A Laboratory Manual", Cold Spring Harbor Laboratory Press, Cold Spring Harbory N.Y., pp. 660-661 and 667.
Sahgal (1987) Psychopharmacology 93(2): 243-249.
Engelmann et al (1992) Neurosci Lett. 142:69-72.
Chemical Abstracts 118(17): 161345m, vol. 17, No. 2-3, 1992.
Chemical Abstracts 113(9): 71509K, vol. 53, No. 3, 1990.
C. Lin, R. Liu & Y. Du, Cysteinyl Methyl Ester of AVP (4-8), a Potent Agonist on the Maintenance of Passive Avoidance in Rats, Peptides, vol. 11, pp. 633-639, 1990.
A Major Metabolite of Arginine Vasopressin in the Brain is a Highly Potent Neuropeptide, Science, vol. 221, pp. 1310-1312, J.P.H. Burbach, G.L. Kovacs, D. De Wied.
Behavioural Actions of Neurohypophysial Peptides, Proc. R. Soc. Lond. B. 210, 183-195 (1980), D. De Wied.
Vasopressin Antagonists Block Peripheral as Well as Central Vasopressin Receptors, Pharmacology Biochemistry & Behavior, vol. 21, pp. 393-400, 1984, D. De Wied, O. Gaffori, J. M. Van Ree & W. DeJong.
Central Target For The Behavioural Effects of Vasopressin Neuropeptides, Nature vol. 308, (1984), pp. 276-278, D. De Wied, O. Gaffori, J. M. Van Ree & W. de Jong.
Structure Activity Relationship Studies With C-Terminal Fragments of Vasopressin and Oxytocin On Avoidance Behaviors of Rats, The Journal of Pharmacology and Experimental Therapeutics, vol. 241, pp. 268-274, D. De Wied, O. Gaffori, J.P.H. Burbach, G.Kovacs, J. VanRee.
Neonatal Administrations of a Vasopressin Analog (DDAVP) and Hypertonic Saline Enhance Learning Behavior in Rats, Peptides, vol. 9, pp. 717-721, (1988), X. Chen, Z. Chen, R. Liu & Y. Du.
Duffy Patricia A.
Knode Marian C.
Shanghai Institute of Biochemistry
LandOfFree
Memory enhancing peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Memory enhancing peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Memory enhancing peptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2397776